By Katryna Perera ( May 27, 2022, 3:24 PM EDT) -- Biopharmaceutical company Spero Therapeutics Inc. has been hit with a proposed class action suit from an investor who claims the company made false and misleading statements about the regulatory approval of one of its developed drugs, causing stock-price drops and financial damages to shareholders as a result....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.